Well this is great news & obviously the MSAC meeting went well, for continuation on with the process of application for a Medicare rebate for PromarkerD. There was a lot of research related evidence in that initial application & that obviously bode well, & necessary to provide rationale for all regulatory approvals.
As we know full well, all these regulatory steps take time & FDA held up by COVID. I think UK/EU news & the FDA Application news will be prior, but it’s great to hear some news on this @Eqz in Australia.
The ANN was pretty succinct & very non-rampy. At the moment, biotechs are taking a big hit on SPs (Macro Markets). That’s really disappointing across all my biotech investments, so we we shouldn’t take this as some kind of fundamental slap in the head.
We have had some terrific progress in our pipeline recently (see latest ANNs) & are faring well all considered in the current climate.
GLTAH, & FWIW I will be holding through all this garbage & using this opportunity to buy more in various stocks…someone is buying the panic seller’s shares. Lol
PIQ Price at posting:
$1.24 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)